It has been reported that cytoplasmic cGAS activates innate immune signaling in response to DNA damage or genome instability in tumor cells and thereby promotes the activation of CD8+ T cells and the efficacy of immune checkpoint blockades therapies64–66. This evidence concerns the gene CD8A and neoplasm.